On 29 January 2021, the Kemp Little team joined Deloitte Legal. Click here to view the press release.

As of 30 January 2021, Kemp Little LLP ceased to operate as a firm of solicitors and practice law and ceased to be regulated and authorised by the Solicitors Regulation Authority.

Kemp Little LLP has been re-named KL Heritage LLP.

If you are looking to contact a specific individual to seek legal advice or in respect of any other business relationship, please contact Deloitte Legal.

If you are seeking to contact the old Kemp Little LLP in relation to a previous business relationship or matter, please get in touch with KL Heritage LLP.

For enquiries relating to Kemp Little technology products and training portal, please email deloittelegal@deloitte.co.uk

 


 

Kemp Little is a trade name used under licence by KL Heritage LLP (formerly Kemp Little LLP, registered number OC300242 and VAT number 182 8854 65).

On 29 January 2021, the Kemp Little team joined Deloitte Legal.  As of 30 January 2021, Kemp Little ceased to operate as a firm of solicitors and practice law. From this date Kemp Little ceased to be authorised and regulated by the Solicitors Regulation Authority and is being re-named KL Heritage LLP.

All references to Kemp Little herein are references to KL Heritage LLP, which used to carry on business in that name.

KL Heritage LLP is not connected to or associated with Deloitte Legal or Deloitte LLP in any capacity.

 

Kemp Little
  • Looking for someone?
  • Email us
  • Search
MENU MENU
Insights overview

Employment · 23 September 2015 · Charles Claisse

M&A Diligence: Enforceability of Agreed Remedy Provisions

Contracting parties will often choose to add a degree of certainty to their corporate or commercial contracts by including provisions that stipulate specific remedies for… Read more

more content below

Contracting parties will often choose to add a degree of certainty to their corporate or commercial contracts by including provisions that stipulate specific remedies for specific contractual events.  For example, when a party breaches a contract, it will typically pay damages to the innocent party in accordance with the common law, however, in some instances, the parties will agree that a specific sum be payable upon a specific or general breach (liquidated damages) or that any advance/deferred payments paid/due to the defaulting party be forfeited upon a specific or general breach.

When negotiating and drafting agreed remedy provisions, careful consideration needs to be given to the doctrine of penalties which bars the enforcement of penalty clauses that compensate beyond the actual loss suffered by the claimant.

Liquidated Damages and Penalties

A comprehensive review of the doctrine of penalties was undertaken by the Court of Appeal in Makdessi v Cavendish Square Holdings [2013] EWCA Civ 1539.  Mr Makdessi sold part of his holding in a company to Cavendish (ultimately).  The sale agreement included various non-compete provisions as regards Makdessi (who remained as a director and continued to hold shares himself) on the basis that the goodwill in the company was considerable and dependent upon Makdessi’s prominence in the market.  The sale agreement provided that, in essence, on a breach of any of the various non-compete provisions by Makdessi, he would become a defaulting shareholder: triggering a sale of his remaining shares in the company to Cavendish and forfeiting unpaid portions of the deferred consideration outstanding to him.  The deferred consideration was to be paid in stages, calculated by reference to profit.

The issue before the Court of Appeal was whether the forfeit of the deferred consideration and sale of shares (the “agreed remedy”) amounted to an unenforceable penalty. The Court of Appeal concluded that it did based on the following general principles:

  • the deferred consideration and discount on the shares was “substantial”;
  • the agreed remedy was “extravagant and unconscionable” in comparison with the greatest loss that could conceivably be proved to have followed from the breach (furthermore, the same consequences applied in respect of a wide range of breaches which fell into different categories of seriousness, many of which could not attract anywhere close to the lost value associated with the forfeit and compulsory sale);
  • the agreed remedy was “intended to deter and penalise” rather than compensate for actual loss;
  • the agreed remedy did not represent a “genuine pre-estimate of actual loss” (this should be an objective assessment of what the parties (at the time the contract was made) could reasonably have expected the anticipated loss to be); and
  • the agreed remedy was not otherwise “commercially justifiable” in the circumstances – if the remedy is particularly harsh, there must be more than merely a commercial reason agreed between parties of equal bargaining power even when competent advice has been provided in respect of the same.

Leaver Provisions

Another example of an agreed remedy is the compulsory acquisition of shareholder-employee shares when their employment terminates (leaver provisions).  Good, early and bad leaver provisions in articles of association, shareholder agreements and employee incentive schemes allow a company (or the other shareholders) to compulsorily acquire the shares of a shareholder-employee who leaves the company:

  • “Good leavers” typically comprise employees who leave due to illness or otherwise on good terms.
  • “Early leavers” typically comprise employees who voluntarily leave the company prior to the expiry of a fixed commitment period.
  • “Bad leavers” typically comprise shareholder-employees who are dismissed for gross misconduct, although often “bad leaver” will simply be a catch-all term covering all employees who are not good or early leavers.

Early and bad leaver provisions will generally require a shareholder-employee to give up their shares for a price less than market value. Depending on the discount applied to the market price, such clauses may be considered unenforceable penalty clauses given that the leaver is required to part with its property at less than market value. The following points should be considered in relation to leaver provisions:

  • The doctrine of penalties only applies to clauses triggered by a breach of contractual duty. Therefore, drafting a leaver provision so that it is triggered by an event other than a breach of contractual duty may avoid the application of the doctrine of penalties altogether.  That said, the courts have (in obiter) previously expressed a willingness to look at the substance of a bargain so it is unlikely that such drafting would save a clause that would otherwise be caught by the doctrine of penalties.
  • To avoid a double jeopardy situation, leaver provisions should be drafted so that any discount on fair value is deducted from any other claims (by the company or other shareholders) against the leaving shareholder in respect of the same conduct.  It would also be best practice to provide for a catch-all statement stipulating that there will be no double recovery in any event.
  • The quantum of the discount applied to leaver shares should be commensurate with the nature, degree and legally-recoverable loss caused by the specific breach of the leaving shareholder.  Consideration should be given to whether it is appropriate to provide for different categories of seriousness of breach, each with a proportionate discount rate (a catch-all definition for “bad leaver”, coupled with a single price for all bad leavers may fall foul of the doctrine of penalties).
  • The mere commercial reasoning that a leaver provision has been inserted to effect a “clean break” or to provide suitable incentives to employees does not guarantee that the leaver provision will be commercially justified and thus enforceable.

Comment

In order to ensure that an agreed remedy is enforceable, it is necessary to give careful consideration to the following factors when negotiating and drafting agreed remedy provisions:

  • Is the remedy proportionate to the greatest actual loss that could conceivably be suffered as a result of each specific breach that triggers the remedy?

OR

  • Is the remedy otherwise commercially justifiable?

For more information, please contact Charles Claisse, Head of Corporate.

  • Share this blog

  • Twitter
  • Facebook
  • Linkedin

Charles Claisse is the head of corporate

Get in touch

View the team

Sign up for our newsletters

  • Share this Blog

  • Twitter
  • Facebook
  • Linkedin

Other stuff you might like

  1. Webinar | Engaging contractors: your new obligations under the Off Payroll Working Rules
  2. Webinar | People and Pandemic: A U-turn on returning to work and the new Job Support Scheme
  3. UK Government publish further details on the points-based immigration system
The hottest topics in technology
  • Adtech & martech
  • Agile
  • Artificial intelligence
  • EBA outsourcing
  • Brexit
  • Cloud computing
  • Complex & sensitive investigations
  • Connectivity
  • Cryptocurrencies & blockchain
  • Cybersecurity
  • Data analytics & big data
  • Data breaches
  • Data rights
  • Digital commerce
  • Digital content risk
  • Digital health
  • Digital media
  • Digital infrastructure & telecoms
  • Emerging businesses
  • Financial services
  • Fintech
  • Gambling
  • GDPR
  • KLick DPO
  • KLick Trade Mark
  • Open banking
  • Retail
  • SMCR
  • Software & services
  • Sourcing
  • Travel
close
The hottest topics in technology
  • Adtech & martech
  • Agile
  • Artificial intelligence
  • EBA outsourcing
  • Brexit
  • Cloud computing
  • Complex & sensitive investigations
  • Connectivity
  • Cryptocurrencies & blockchain
  • Cybersecurity
  • Data analytics & big data
  • Data breaches
  • Data rights
  • Digital commerce
  • Digital content risk
  • Digital health
  • Digital media
  • Digital infrastructure & telecoms
  • Emerging businesses
  • Financial services
  • Fintech
  • Gambling
  • GDPR
  • KLick DPO
  • KLick Trade Mark
  • Open banking
  • Retail
  • SMCR
  • Software & services
  • Sourcing
  • Travel
Kemp Little

Lawyers
and thought leaders who are passionate about technology

Expand footer

Kemp Little

138 Cheapside
City of London
EC2V 6BJ

020 7600 8080

hello@kemplittle.com

Services

  • Commercial technology
  • Consulting
  • Disputes
  • Intellectual property
  • Employment
  • Immigration

 

  • Sourcing
  • Corporate
  • Data protection & privacy
  • Financial regulation
  • Private equity & venture capital
  • Tax

Sitemap

  • Our people
  • Insights
  • Events
  • About us
  • Contact us
  • Cookies
  • Privacy
  • Terms of use
  • Complaints
  • Debt recovery charges

Follow us

  • Twitter
  • LinkedIn
  • FlightDeck
  • Sign up for our newsletters

Kemp Little LLP is a limited liability partnership registered in England and Wales (registered number OC300242) and is authorised and regulated by the Solicitors Regulation Authority. Its registered office is 138 Cheapside, London EC2V 6BJ. The SRA Standards and Regulations can be accessed by clicking here.

  • Home
  • Our people
  • Services
    • Business restructuring and reorganisation
    • Commercial technology
    • Consulting
    • Corporate
    • Data protection & privacy
    • Digital content & reputation risk
    • Disputes
    • Employment
    • Financial regulation
    • Immigration
    • Innovation
    • Intellectual property
    • Private equity & venture capital
    • Sourcing
    • Tax
    • Travel
  • Resources
  • Insights
  • Covid 19: Your Business Continuity
  • Events
  • About us
    • Who we are
    • Our social responsibilities
    • Our partnerships
    • Join us
  • Contact us
  • FlightDeck
  • Sign up for our newsletters
  • Follow us
    • Twitter
    • LinkedIn
close
close
close

Send us a message

Fill in your details and we'll be in touch soon

[contact-form-7 id="4941" title="General contact form"]
close

Sign up for our newsletter

I would like to receive updates and related news from Kemp Little *

Please select below any publications that you would like to receive:

Newsletters

close

Register for future event information

[contact-form-7 id="4943" title="Subscribe to future events"]
close
close
Generic filters
Exact matches only

Can't remember their name? View everyone

  • Home
  • Our people
  • Services
    • Business restructuring and reorganisation
    • Commercial technology
    • Consulting
    • Corporate
    • Data protection & privacy
    • Digital content & reputation risk
    • Disputes
    • Employment
    • Financial regulation
    • Immigration
    • Innovation
    • Intellectual property
    • Private equity & venture capital
    • Sourcing
    • Tax
    • Travel
  • Resources
  • Insights
  • Covid 19: Your Business Continuity
  • Events
  • About us
    • Who we are
    • Our social responsibilities
    • Our partnerships
    • Join us
  • Contact us
  • FlightDeck
  • Sign up for our newsletters
  • Follow us
    • Twitter
    • LinkedIn